-
41
Intratumoral <i>Fusobacterium nucleatum</i> in Pancreatic Cancer: Current and Future Perspectives
Published 2024-12-01Subjects: Get full text
Article -
42
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
Published 2025-02-01Subjects: “…pancreatic cancer…”
Get full text
Article -
43
Endoscopic biliary drainage for distal bile duct obstruction due to pancreatic cancer
Published 2025-01-01“…Approximately 60% of pancreatic cancers occur in the pancreatic head and may present as obstructive jaundice due to bile duct invasion. …”
Get full text
Article -
44
Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
Published 2012-01-01“…Background and Aims. 5-year survival in patients with pancreatic cancer is poor. Surgical resection is the only potentially curative resection. …”
Get full text
Article -
45
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
Published 2025-02-01“…Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. …”
Get full text
Article -
46
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
Published 2018-01-01Get full text
Article -
47
The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
Published 2025-01-01“…Abstract In the context of the global increase in early-onset tumours, investigating the global disease burden caused by early-onset pancreatic cancer (EOPC) is imperative. Data on the burden of EOPC were obtained from the Global Burden of Disease Study 2021. …”
Get full text
Article -
48
Folded and Unfolded Conformations of Proteins Involved in Pancreatic Cancer: a Layman's Guide
Published 2010-01-01“…Pancreatic cancer (PC) is one of the most difficult illnesses to treat, since the 5-year survival rate is lower than 5% in patients and no substantial advances in its treatment have been achieved in the last 20 years. …”
Get full text
Article -
49
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Published 2024-01-01Get full text
Article -
50
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Published 2025-01-01“…Abstract Lipid metabolism in cancer is characterized by dysregulated lipid regulation and utilization, critical for promoting tumor growth, survival, and resistance to therapy. Pancreatic cancer (PC) is a highly aggressive malignancy of the gastrointestinal tract that has a dismal 5-year survival rate of less than 10%. …”
Get full text
Article -
51
Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
Published 2020-07-01Subjects: “…pancreatic cancer…”
Get full text
Article -
52
Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer
Published 2017-01-01“…Cancer stem cells (CSCs) have been identified as a subpopulation of stem-like cancer cells with the ability of self-renewal and differentiation in hematological malignancies and solid tumors. Pancreatic cancer is one of the most lethal cancers worldwide. …”
Get full text
Article -
53
Novel therapy modalities combining photodynamic therapy and liposomal cisplatin for pancreatic cancer treatments
Published 2025-03-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
54
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
Published 2025-01-01Subjects: Get full text
Article -
55
AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility
Published 2025-01-01“…In gene panels developed for early diagnosis of pancreatic cancer, high AHNAK2 mRNA expression was one possible biomarker. …”
Get full text
Article -
56
The Utility of Repeat Endoscopic Ultrasound-Guided Fine Needle Aspiration for Suspected Pancreatic Cancer
Published 2010-01-01“…The utility of repeat EUS in patients with suspicion for pancreatic cancer after non-diagnostic EUS-FNA study is not well established. …”
Get full text
Article -
57
CIRBP Regulates Pancreatic Cancer Cell Ferroptosis and Growth by Directly Binding to p53
Published 2022-01-01“…Pancreatic cancer is one of the most malignant gastrointestinal tumors, and it is of great significance to explore the molecular mechanism of its progression and find new biological therapeutic targets. …”
Get full text
Article -
58
Pathophysiological mechanisms, multidimensional diagnostics and modern therapies of pruritus in pancreatic cancer: review and perspectives
Published 2025-01-01Subjects: Get full text
Article -
59
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Published 2024-12-01Subjects: “…pancreatic cancer…”
Get full text
Article -
60
Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article